chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was vaccinated at workplace on Thursday, September 2nd at 1pm.  Infection nurse contacted facility today, September 3rd at approximately 2pm. Notifying office manager about the event that had occurred.  This morning the patient was standing in the laundry room, ?felt faint and tried grabbing onto the folding table for support.? She doesn?t remember falling, but her coworker heard a bang and ran in to find her lying on the floor.  The patient seemed fine after a few minutes but we called her family to come pick her up and encouraged her to go to urgent care. Family and patient refused any medical treatment, per the facility.  The patient informed the infectious control nurse that her medical history includes dizziness., The patient was fine after the vaccine was administered on September 2nd, and reports that her legs started aching later that night and she felt really tired.  This morning she felt achy and tired, but not enough that she had to stay home.
1st injection I had no reactions or symptoms.  2nd shot:  3 days after shot I woke up and my joints hurt so bad I was unable to walk.  I have since had extreme joint pain and many days unable to walk very good.  My knees are in extreme pain every day with my other joints  hurting as well.  I started doctoring for my knees on August 30, 2021 to see what help I can get with the pain and joint swelling.  I have had multiple knee surgeries prior to the vaccine and have knee replacements.  The pain has not subsided since the onset of pain after my 2nd shot.  My Dr. has ordered some tests at this point.  My daily struggles with pain are extreme and make my daily functions hard to live with.
2 weeks after covid 19 vaccine, had severe multiple allergic reactions never experienced.; Suture reaction to surgical site; allergic flare up of previously healed and closed nerve block locations; slight increase in eosinophils, CRP; slight increase in eosinophils, CRP; increase in platelets; This is a spontaneous report from a contactable nurse (patient). A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number Ek5t30), intramuscularly on 20Dec2020 12:00 at single dose for covid-19 immunization. Vaccine location was right arm and it was the first dose. Patient is not pregnant. The facility type vaccine was workplace clinic. Medical history included hypothyroidism from an unknown date. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. 2 weeks after COVID-19 vaccine on 01Jan2021 21:00, patient had severe multiple allergic reactions never experienced. Suture reaction to surgical site, allergic flare up of previously healed and closed nerve block locations, then later apparent full body reaction to Bactrim. At least 3 allergic reactions never experienced before with slight increase in eosinophils, CRP, and increase in platelets. Severe Suture rejection to extremely common sutures. The adverse events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization one day. Patient received IV methylprednisone, Benadryl, famotidine as treatment for the adverse events. The outcome of events was recovered in Jan2021. Known allergies included apparent Bactrim allergy, in spite of allergic symptoms starting 4 days prior to taking Bactrim.; Sender's Comments: Based on the information currently provided, the vaccination might trigger the onset of multiple allergic reactions accompanying with lab abnormalities, considering the plausible temporal relationship.  Severe allergic reaction is the known risk for the product. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
There were no notable side effects from the vaccine. It was a live virus and his last live virus was given on  5/16/2023, less than 28 days.
4/15/2022: Treated at Hospital ER for: Chest Discomfort, Rapid Afib with RVR. Arrived to ER vis Rescue at 810pm and discharged home at 1145pm.
Rash to back, chest and abdomen. Some lesions vesicular, though all small and with erythematous macular base. Also with fever. Started on Valtrex. PCR of lesion negative for VZV--little fluid obtained.  After 4 days of Valtrex, patient was improving and was switched to optical steroid cream. She continued to improve. At the time of presentation to the hospital for the above, she had blood cultures that turned positive for Streptococcus.
27 hours after injection I began to feel a migraine, chills, incredibly tired and my temperature went up to 100.8.  My chest was tight and achy and my oxygen levels stayed at about 88.  I slept about 10 hours and woke up feeling fine.  My chest is sore and achy but better than yesterday.
1st dose 2020, 2nd 05Dec2022; This case was reported by a other health professional via sales rep and described the occurrence of drug dose administration interval too long in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received 1st dose in 2020).   On 5th December 2022, the patient received the 2nd dose of Shingrix. On 5th December 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 06-DEC-2022 Reporter's Comments: The reporter had a 66 year old patient who received his first dose of Shingrix in 2020.  He received his second dose yesterday (from date of reporting).  The reporter asked if he should receive another dose in 2-6 months or not. The reporter requested guidance on dosing for patients were unable to complete the 2-dose series within the indicated time frame. No Follow up requested in the message, no lot number or vaccine expiration date provided. Additional Supportive Information: The patient received 2nd dose of Shingrix vaccine yesterday after receiving 1st dose in 2020, later than the recommended standard schedule, which led to lengthening of the vaccination schedule.
Pt received FLUZONE Quad 10/13/14 and reported vomiting same night. Pt also had fever and "felt terrible" - aches and pains and run down/tired.
19AUG92 Elevated t102-103.8; pt had a sz, required ER visit; 01SEP92: no recurrence of episode since 19AUG92; no tests were performed; this was pt's last dose DTP;
Developed a hive (exactly a week after); Itching rash around the area (exactly a week after); A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 Vaccine, and who developed a hive or itching rash around the area.    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.    On 07-Jan-2021, approximately a week prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 I(Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.    On 07-Jan-2021, patient developed a hive or itching rash around the area. Treatment information was not provided.    Action taken with mRNA-1273 in response to the events was not provided.    The outcome of the events developed a hive or itching rash around the area was considered unknown.; Reporter's Comments: This case concerns a female of unknown age who experienced nonserious expected events of injection site urticaria and injection site pruritus. Event onset occurred 8 days after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
ANXIETY, DEPRESSION, DIARRHEA, HEAD ACHE, DISSINESS, BLOOD PRESSURE EXTREMELY INCREASES AND DECREASES, HIGH POTTASSIUM LEVELS, NO BENEFITS FROM TREATMENTS. STARTED WEEK AFTER SECOND SHOT AND CONTINUES CURRENTLY.
Employee presented in the occupational Health clinic on 10/21/08 for a influenza vaccination.  He told the RN that he had a mild URI illness but no fever and he consented to getting Flulaval after a brief discussion about postponing it until he felt well.  The following day he was admitted to Hospital from home with possible pneumonia.  Within days he was transferred by helicopter to Medical System where he remains in treatment.  The information we have comes via his supervisor.  He is reportedly on a ventilator and receiving steroids.  We have provided the hospital with the employee medical record.  12/22/2008 MR received for DOS 10/24-11/13/2008 with D/C DX:  Acute interstitial pneumonitis, respiratory failure, pulmonary embolism, acute renal failure and death. Pt transferred from local hospital (admitted 10/22/08)for hypoxemic respiratory failure following 6 months of progressive dyspnea and evaluation for lung transplant. On admission T=96.5'F, intubated and sedated with O2 sat of 96%, coarse bilateral breath sounds and tachycardic. Tx for pneumonia but developed DVT with PE which was symptomatic on 11/10/08.  Started on heparin but unable to be aroused from sedation. Platelet count dropped. Pt suffered a PEA arrest on 11/13/08 with restoration of BP and heartrate with CPR however BP difficult to maintain despite high dose pressors.  Life support withdrawn and pt died at  10:41 on 11/13/08. Autopsy  reports COD as Pulmonary Fibrosis due to a combination of acute pneumonia and organizing diffuse alveolar damage superimposed on a background of chronic interstitial lung disease and emphysema.
Initial information was received on 31 October 2008 from another manufacturer whose initial reporter was a consumer (patient's parent).  A female patient received DTP (manufacturer, lot number, and date was not reported) and stopped breathing temporarily and experienced seizures for a year.  Recovery status was not reported.  No other information was provided.  List of Documents held by Sender: None.
Next day after vaccination felt very faint, really bad, very dizzy and started throwing up. White as ghost c/o burning in lower extremities. Saw physician who was concerned about heart rate and BP and kept him in office for a period of time to monitor.
4/21/2021 4:00 am Patient started feeling sick and had a fever. He took Tylenol for the fever and symptoms. Around 10:00am he still felt sick and took another dose of Tylenol. Around 11:00am Patient stated complaining of chest pains. He was curled up on the couch in pain. I called his doctor and they advised to take him to the ER. Arrived at the ER around 11:21am and he was seen without me because I had my children with me and covid restrictions.
L axillary lymph node swelling.  Tongue swelling and discomfort enough to warrant ER visit
Red rash, hot to the touch, started next morning around 8 am. Treated w/advised to take ibuprofen and cold packs.
Patient received incomplete booster due to syringe malfunction. Patient was given 0.3ml dose of pfizer to compensate for incomplete dose
Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 18 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 12Apr2021 14:30 (Lot number: EP6955) at the age of 18 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "pollen" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, lot number: EP6955, lot: Unknown, administration date:22Mar2021, administration time:02:30 PM), administration date: 22Mar2021, when the patient was 18 years old, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 13Apr2021 17:00, outcome "recovered" (Apr2021), described as "Fatigue". Therapeutic measures were not taken as a result of fatigue.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID19. Since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Child received 2 mo vaccines (PEDIARIX, Hib, PCV, Rota) without reaction. Rec'd 4 mth vaccines (as above), 12/5/14 developed abscess in bl thighs-1/23/15, culture negative, then rec'd PEDIARIX at center on 3/18/15 -> abscess. Culture negative. TX cephalexin.
I had no adverse reactions for the first 2 doses of the  Moderna vaccine. On the 3 dose, I experienced chills, fatigue, headache, body aches, and fever, which started roughly 12 hours after administration. These symptoms were severe for 1 day and resolved over the course of 3-4 days. Then, roughly 9 days after the 3rd dose, I started experiencing small itchy patches on my skin, which developed into hives 2 days later. I discontinued taking my supplements thinking that it might be the cause, to no avail (I have taken all of the listed supplements for prolonged periods of time, 8+ months). In addition, I have had no significant changes to my diet and have not introduced any new foods. I am currently experiencing small patches of hives that move around my body throughout the day and severe itchiness, primarily on my ancles, feet, hands, armpits, and scalp. The itchiness and hives come and go - no rhythm or reason. Taking Zyrtec resolves 95% of my symptoms. However, if I discontinue Zyrtec, my symptoms return. I am traveling internationally on 1/8 and plan to be evaluated at my final destination should my symptoms persist.
Fast heart beat - 120 beats per minute - lasted until 7:30 p.m.  Administered Benadryl as directed by nurses on call at urgent care.
Half the dose on elbow; A spontaneous report  was received from a consumer concerning herself, a 47-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced half the dose ended up on elbow (underdose).  The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.  On 05 Feb 2021, the patient received her first of the two planned vaccine doses of mRNA-1273 (Lot number: 013M2CA), intramuscularly, in the left non dominant arm, for prophylaxis of COVID-19 infection.   On 05 Mar 2021, the patient received her second of the two planned doses of mRNA-1273 (Lot number: 029A21A), via unknown route, in the left non dominant arm, for prophylaxis of COVID-19 infection. It was reported that the patient noticed during vaccine administration that half the dose ended up on elbow.   Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event was not applicable.   The outcome of event was considered resolved on 05 Mar 2021.; Reporter's Comments: This report refers to a case of Underdose,  for mRNA-1273, lot #: 029A21A,  with no associated AEs.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054715:1st dose
I am having serious acne on my chin.  At 66, I don't generally acne, but I have had a large outbreak on my chin. One or two new ones per day and the old ones don't easily heal. It is like my immune system is in overdrive. Nothing seems to affect the outbreak.  I have tried Neosporin, Cortaid and Oxy 10. They keep popping up.
Administered .5 ml of H1N1 vaccine when should have been .25 ml of H1N1.
Information has been received from a physician concerning a 14 week old male who on 08-JAN-2008 was vaccinated PO with a 2.0 ml dose of ROTATEQ (lot# 658383/1389U). Concomitant vaccinations administered on that same day included a dose of Hib conj vaccine (tet toxoid) (ACTHIB), a dose of PREVNAR, a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and a dose of poliovirus vaccine inactivated (unspecified). On 07-FEB-2008 the patient's fever started and this was when the physician felt was the onset of Kawasaki disease. Additional symptoms of Kawasaki's disease that the patient experienced included conjunctivitis and rash. On 08-FEB-2008 the patient was admitted to the hospital and was discharged on 11-FEB-2008. Subsequently, the patient recovered. The physician stated that "according to things I've read I don't think it was related to ROTATEQ." There was no product quality complaint. Additional information has been requested.  5/9/08 Reviewed hospital medical records for 2/8-2/11/2008. FINAL DX: Kawasaki disease Records reveal patient experienced fever, rash, cracked lips & red eyes, conjunctivitis, cough, runny nose, irritability, reduced oral intake x 1 week.  Cardio & ID consult done.  Tx w/IVIG & ASA.  Remained afebrile during hospitalization.  Improved & d/c to home on ASA w/cardio, ID & PCP f/u.
Narrative:  Pt admitted to hospice 3/8/21 for GI bleed. Death within 42 days of covid vaccination
Fully vaccinated with booster on 11/9/21. Breakthrough COVID 11/12 with inpatient admit.
Pt received MMR on 06/28/06 and 8/15/06, pt got pregnant around 8/10/06.
Pt reports full body hives started 2 days after receiving vaccination.  Hives would last one day then resolve, she states has happened 3 times since then.  Pt presented to facility 11/19.  She had her vaccine at clinic on 11/12.  She states she contacted her PCP's office which is clinic and she was told to come to prompt care or ER to have hives confirmed.  Dr  saw pt in prompt care, but is not the patient's PCP.  Pt sees NP who is under Dr.
Menactra was given instead of Prevnar. Mother informed; child slept after getting vaccine. No reaction. Mother spoke with doctor.
Redness at vaccination site with localized fever and lymph node swelling. Treatment: Keflex 500 mg 2 bid, Motrin 800 mg 1 tid.
Chills, low-grade fever, extreme soreness/pain in upper arm - had difficult time raising arm at all, rapid heart rate, some nausea.
This case was reported by a other health professional via call center representative and described the occurrence of injection site rash in a 56-year-old female patient who received SHINGRIX (batch number 9779K, expiry date 11th October 2020). On 4th May 2018 14:00, the patient received the 1st dose of SHINGRIX (intramuscular). In May 2018, less than a week after receiving SHINGRIX, the patient experienced injection site rash and injection site hives. The patient was treated with BENADRYL (nos). On an unknown date, the outcome of the injection site rash and injection site hives were not recovered/not resolved. It was unknown if the reporter considered the injection site rash to be related to SHINGRIX. The reporter considered the injection site hives to be possibly related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on left deltoid. The patient developed a rash and hives close to the injection site a few days after receiving the SHINGRIX vaccine. The patient contacted pharmacist who recommended BENADRYL cream.
pt recv vax 13AUG96 & 11FEB98 pt exp chickenpox consisting of a dozen vesicles & lesions;three of four of them were 1mm in size & crusting over;
weakness, fever, wheezing, fast heartbeat, sore throat for 24 hours. Given  Tylenol 1 1/2 tsp.
hard welt under the skin the width of 1 x.5 inches. It?s a little warm to the touch and slightly sore.
Headache and dizziness 10 minutes after shot.  Still having same symptoms and feeling unbalanced.
I had local pain, irritation, swelling, and decreased range of motion within 30 min. of the injection to the left arm. Within 4 hours all of that pain radiated to my left shoulder and neck. Within 24 hours I continued to have all the previous mentioned symptoms along with palpitations, anxiety, bilateral hand and feet muscle spasm that ascended to the forearms and calves. At 35 hours post injection while running/sprinting both of my quadriceps became completely tight/frozen causing me to tear my right quad and strain my left quad. 48 hours post injection I continue to have bilateral hand and feet spasms, muscle cramping, nervous feeling that ascends along with intense thigh pain.
I was expected to get my period the day after I received my booster. My cycle is always on time, so I was anticipating getting it.  Instead, my period was delayed by exactly two weeks. Throughout this time I have experienced extremely heavy cramping, bloating, and mood swings off and on every day since. I took two pregnancy tests because I was so late but my period finally came after two weeks.
Lightheadedness; shortness of breath; rash below throat. Zyrtec; steroid pills.
9/28- tiredness 9/29- aching in bones and joints 9/30- all the above with added swelling in hands and feet.  Left side was worse. (side of the injection) Ibuprofen helped with pain. Numbness in pinky fingers and toes. It got progressively better as the week went on.  I went back to the clinic  10/3.  They recommended that I take the rest of the week off.  Slept most of the day 10/3.  By Monday I was feeling close to being back to my old self.
I'm have shooting or pinching pain in may arms and legs that is keeping me up at night and is worse when my body is at rest. It started on May 12th with a really bad episode of shooting tingling and numbness in the arm I got my shot in( my left) I thought I was having a heart attack so I went to the dr they checked my heart and took my blood and everything was normal. I am supposed to get my second dose on Monday 5/24 but I don't want this to get any worse
This spontaneous report as received from an unspecified reporter refers to a patient of unknown age and gender. On 25-NOV-2014, the patient was vaccinated with a dose of M-M-R II (route, dose, frequency and lot # not reported) which had undergone an temperature excursion. This is one of several reports from the same source. Additional information has been requested.
Myalgia, Arthralgia, Fever, fatigue, chills Narrative:  Other Relevant History:
Headaches  whenever she's around someone who is fully vaccinated; This is a spontaneous report from contactable consumer (patient) via a Pfizer sponsored Program  Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot/batch number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patients medical history and concomitant medications were not reported. The patient experienced headaches whenever she was around someone who was fully vaccinated. The outcome of event was unknown.  Follow-up attempts were completed. Information about lot/batch number cannot be obtained. No further information was expected.
positive for covid on 1/8 and negative on 1/11 and 1/14. considered a false positive to covid